dc.contributor.author | TEKKELİ, ŞERİFE EVRİM | |
dc.contributor.author | Onal, Armagan | |
dc.contributor.author | Durmus, Zehra | |
dc.date.accessioned | 2021-03-04T19:49:04Z | |
dc.date.available | 2021-03-04T19:49:04Z | |
dc.identifier.citation | TEKKELİ Ş. E. , Durmus Z., Onal A., "Determination of atorvastatin in human plasma by magnetic solid-phase extraction combined with HPLC and application to a pharmacokinetic study", JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, cilt.39, ss.852-860, 2016 | |
dc.identifier.issn | 1082-6076 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_919e1fa2-fb26-4627-afff-88ed14a2fef9 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/98227 | |
dc.identifier.uri | https://doi.org/10.1080/10826076.2016.1275002 | |
dc.description.abstract | A simple and sensitive analytical procedure by solid-phase extraction method combined with high-performance liquid chromatography and using of graphene-magnetite nanomaterials as sorbent has been developed for the determination of atorvastatin in human plasma. A magnetic solid-phase extraction method as a simple, fast, and efficient extraction technique has been used for sample preparation. A solid nanocomposite material, graphene nanosheets decorated with magnetite nanoparticles, was used as a magnetic adsorbent and the adsorption process was optimized in this study. RP C18 column was used with mobile phase composed of acetonitrile-10mM orthophosphoric acid by isocratic elution with the flow rate of 1mLmin(-1). Fluorimetric detection was used by the excitation wavelength at 282nm and the emission wavelength at 400nm. It was found that the calibration curve was linear in the 30-150ngmL(-1). Limit of detection and limit of quantitation values were found to be 10 and 30ngmL(-1), respectively. The intra-day and inter-day relative standard deviation values were less than 5.27%. It has been concluded that the new developed method provides fast, simple, cost reduced, and sensitive assay for atorvastatin determination in human plasma. This method is also applied to a pharmacokinetic study. | |
dc.language.iso | eng | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Biyokimya | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Sitogenetik | |
dc.subject | Analitik Kimya | |
dc.subject | Temel Bilimler | |
dc.subject | Temel Bilimler (SCI) | |
dc.subject | BİYOKİMYA VE MOLEKÜLER BİYOLOJİ | |
dc.subject | KİMYA, ANALİTİK | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Kimya | |
dc.subject | Biyoloji ve Biyokimya | |
dc.subject | BİYOKİMYASAL ARAŞTIRMA YÖNTEMLERİ | |
dc.title | Determination of atorvastatin in human plasma by magnetic solid-phase extraction combined with HPLC and application to a pharmacokinetic study | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES | |
dc.contributor.department | Bezmiâlem Vakıf Üniversitesi , Eczacılık Fakültesi , Analitik Kimya Anabilim Dalı | |
dc.identifier.volume | 39 | |
dc.identifier.startpage | 852 | |
dc.identifier.endpage | 860 | |
dc.contributor.firstauthorID | 227830 | |